Autism and intellectual disability due to a novel gain-of-function mutation in UBE3A
Anna M. Gunelson, Kwang‐Soo Kim, Connolly Steigerwald, Devorah Segal, Nicolas J. Abreu, Jason J. Yi
Abstract
Open-access reader
Anna M. Gunelson, Kwang‐Soo Kim, Connolly Steigerwald, Devorah Segal, Nicolas J. Abreu, Jason J. Yi
Abstract
Open-access reader
Abstract The loss of maternal UBE3A causes Angelman syndrome whereas its duplication is associated with a heterogeneous neurodevelopmental disorder. Here, we describe two affected brothers who possess a novel UBE3A L734S variant that is not present in two neurotypical siblings. The UBE3A L734S variant was confirmed to be maternally inherited, and the affected individuals exhibited early global developmental delay, ongoing learning difficulties, and autistic features. Their phenotypes were inconsistent with Angelman syndrome. Biochemical characterization showed the UBE3A L734S variant causes a dramatic increase in the activity of the UBE3A enzyme, suggesting that a gain in UBE3A activity is the driver of neurodevelopmental disease. Our observations document an emerging class of neurodevelopmental disorders caused by gain-of-function mutations in UBE3A.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract The loss of maternal UBE3A causes Angelman syndrome whereas its duplication is associated with a heterogeneous neurodevelopmental disorder. Here, we describe two affected brothers who possess a novel UBE3A L734S variant that is not present in two neurotypical siblings. The UBE3A L734S variant was confirmed to be maternally inherited, and the affected individuals exhibited early global developmental delay, ongoing learning difficulties, and autistic features. Their phenotypes were inconsistent with Angelman syndrome. Biochemical characterization showed the UBE3A L734S variant causes a dramatic increase in the activity of the UBE3A enzyme, suggesting that a gain in UBE3A activity is the driver of neurodevelopmental disease. Our observations document an emerging class of neurodevelopmental disorders caused by gain-of-function mutations in UBE3A.
Key concepts: UBE3A, Angelman syndrome, Neurodevelopmental disorder, Neurotypical, Intellectual disability, Autism, Genetics, Loss function